JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kroeker, T. R.
Right arrow Articles by Dale, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kroeker, T. R.
Right arrow Articles by Dale, P. S.
Journal of the American Podiatric Medical Association
Volume 99 Number 4 364-366 2009
Copyright © 2009 American Podiatric Medical Association

Plantar Fibromatosis Masquerading as Metastatic Melanoma

Teresa R. Kroeker, MD *, Sarah B. Fisher, BS {dagger}, Allison Lisle, MD {ddagger} and Paul S. Dale, MD §

* Department of General Surgery, University of Missouri, Columbia, MO.
{dagger} University of Missouri College of Medicine, Columbia, MO.
{ddagger} Department of Pathology, University of Missouri Hospital, Columbia, MO.
§ Department of Surgical Oncology, University of Missouri, Columbia, MO.

Corresponding author: Teresa R. Kroeker, MD, Department of General Surgery, University of Missouri, One Hospital Dr, Columbia, MO 65212. (E-mail: teresaruthk{at}yahoo.com)

Abstract

We present the evaluation and treatment of a 59-year-old male with a medical history significant for multiple recurrences of malignant melanoma. The patient was found to have increased focal uptake of his right foot on fluorodeoxyglucose positron emission tomography. Given the patient’s clinical history, the increased uptake was suspected to be recurrence of his disease. The nodule was surgically excised and was later pathologically diagnosed as benign plantar fibromatosis. To our knowledge, only one other case report of plantar fibromatosis demonstrating increased fluorodeoxyglucose positron emission tomography uptake exists. Given the distinct prognostic differences between plantar fibromatosis and recurrent malignant melanoma, clinicians should be aware of the possibility of such false-positives with fluorodeoxyglucose positron emission tomography during oncologic surveillance. (J Am Podiatr Med Assoc 99(4): 364–366, 2009)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Podiatric Medical Association.